Yuqing Zhu
Hefei, 230026, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
An Optimized Protocol for the Generation of Vascular Organoids from Human Induced Pluripotent Stem Cells.
Journal: Journal of visualized experiments : JoVE
Published: September 04, 2026
Single cell CRISPR screen identifies antagonism between Nsd1-H3K36me2 and Ezh2-H3K27me3 orchestrates pluripotency transition.
Journal: Stem cell reports
Published: January 11, 2026
Application and developing various evaluation indicators for validating the effectiveness of the harmonisation protocol in multiple scenarios and applying to a multi-center real-world cohort.
Journal: Clinical chemistry and laboratory medicine
Published: January 11, 2026
Effects of small incision cataract surgery and routine ultrasonic phacoemulsification on vision recovery, anterior segment parameters and corneal regularity.
Journal: Technology and health care : official journal of the European Society for Engineering and Medicine
Published: May 07, 2025
Producing an Anti-dsDNA Antibody Reference Reagents to Calibrate Different Quantitative Assays in China.
Journal: International journal of rheumatic diseases
Published: April 24, 2025
Bistable Otx2-Id1 circuitry governs a developmental transition state in the pluripotency continuum.
Journal: The Journal of cell biology
Published: April 10, 2025
Antagonistic interaction between Notch3 signaling and CREB/KLF15 pathway in regulating the phenotypic alterations of glomerular parietal epithelial cells in adriamycin-induced nephropathy.
Journal: Experimental cell research
Published: January 29, 2025
Moyamoya disease: epidemiology, clinical features, pathogenesis, diagnosis and therapeutic interventions.
Journal: Molecular biomedicine
Published: December 17, 2024
Author Correction: Multiplexed bulk and single-cell RNA-seq hybrid enables cost-efficient disease modeling with chimeric organoids.
Journal: Nature communications
Published: June 05, 2024
Author Correction: A second-generation M1-polarized CAR macrophage with antitumor efficacy.
Journal: Nature immunology
Published: December 18, 2023
Last Updated: 09/26/2026